Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1621 | PolarityTE Inc (PTE) | XNAS | US | 2022-12-31 | 10 months ago | USD | 0.24 | 0.00 | 0.00% | 0.97 | 403.47% | Ungraded | 0.00 | 0.00% |
| 1622 | Eiger BioPharmaceuticals Inc (EIGR) | XNAS | US | 2022-12-31 | 1 month ago | USD | 2.30 | 0.00 | 0.00% | 35.85 | 1,558.71% | Ungraded | 0.00 | 0.00% |
| 1623 | Vyne Therapeutics Inc (VYNE) | XNAS | US | 2023-12-31 | 4 days ago | USD | 2.62 | 0.00 | 0.00% | 6.17 | 235.53% | Ungraded | 0.00 | 0.00% |
| 1624 | Creative Medical Technology Holdings Inc (CELZ) | XNAS | US | 2023-12-31 | 4 days ago | USD | 4.40 | 51.02 | 1,159.65% | 7.23 | 164.23% | Ungraded | 0.00 | 0.00% |
| 1625 | ViewRay Inc (VRAY) | XNAS | US | 2022-12-31 | 9 months ago | USD | 0.04 | 0.00 | 0.00% | 0.22 | 539.54% | Ungraded | 0.00 | 0.00% |
| 1626 | Acasti Pharma Inc (ACST) | XNAS | CA | 2023-03-31 | 4 days ago | USD | 2.96 | 0.00 | 0.00% | 14.68 | 495.80% | Ungraded | 0.00 | 0.00% |
| 1627 | Forte Biosciences Inc (FBRX) | XNAS | US | 2023-12-31 | 4 days ago | USD | 0.71 | 0.00 | 0.00% | 0.95 | 134.33% | Ungraded | 0.00 | 0.00% |
| 1628 | Hyperfine Inc (HYPR) | XNAS | US | 2023-12-31 | 4 days ago | USD | 0.80 | 0.00 | 0.00% | 1.10 | 137.53% | Ungraded | 0.00 | 0.00% |
| 1629 | Nuwellis Inc (NUWE) | XNAS | US | 2023-12-31 | 4 days ago | USD | 0.18 | 0.00 | 0.00% | 0.25 | 139.87% | Ungraded | 0.00 | 0.00% |
| 1630 | NCS Multistage Holdings Inc (NCSM) | XNAS | US | 2023-12-31 | 4 days ago | USD | 17.42 | 0.00 | 0.00% | 17.55 | 100.72% | Ungraded | 0.00 | 0.00% |